Bio rad Laboratories Inc (BIO) Annual Balance Sheets

Annual · GAAP · USD millions
Access BIO quarterly Balance Sheets →
The balance sheet data below highlights changes in Bio rad Laboratories Inc's financial position over recent quarters.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent529.80
Restricted Investments, Current RE0.00
Short-term Investments, Total1,010.90
Cash & Short-term Investments1,539.00
Accounts receivable460.60
Inventories740.70
Other Current Assets27.70
Prepaid Expense, Current AS136.50
Total Current Assets2,906.20
Equipment/Property/Plant Net539.90
Goodwill net579.80
Intangible Assets174.30
Long-term investments6,103.60
Other Assets, Noncurrent6,376.30
Operating Lease Right Of Use Asset170.00
Total Assets10,576.50
Liabilities
Accounts Payable, Current AC129.00
Employee-related Liabilities, Current AC172.30
Notes and Loans Payable, Current LO1.30
Other Liabilities, Current141.70
Taxes Payable, Current, Total36.60
Deferred Revenue, Current DE0.00
Total Current Liabilities517.00
Long-term debt1,201.70
Total Long-term Debt1,201.70
Other liabilities, Noncurrent1,404.20
Operating Lease Liability Current36.10
Operating Lease Liability Noncurrent145.70
Total Liabilities3,122.90
Stockholders' Equity
Common Stock Value0.00
Treasury Stock Value-1,009.60
Additional Paid In Capital Common Stock476.00
Retained Earnings / Accumulated Deficit8,176.30
Other Equity-189.10
Common Stockholder's Equity7,453.60
Total Stockholder's Equity7,453.60
Liabilities & Stockholder's Equity10,576.50
4 historic quarters locked

Sign in to unlock the full Bio rad Laboratories Inc balance sheet history.

About Bio rad Laboratories Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 12, 2026
  • Source: bio-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000012208-26-000010

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License